Alexandria New Medical Center (EGX: AMES)
Egypt
· Delayed Price · Currency is EGP 6.97
0.00 (0.00%)
At close: Sep 11, 2024
AMES Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 294.24 | 277.73 | 261.03 | 275.16 | 225.39 | 213.69 | Upgrade
|
| Revenue Growth (YoY) | 8.23% | 6.40% | -5.13% | 22.08% | 5.48% | 16.34% | Upgrade
|
| Cost of Revenue | 223.47 | 214.54 | 186.87 | 174.17 | 151.71 | 147.48 | Upgrade
|
| Gross Profit | 70.77 | 63.19 | 74.16 | 100.99 | 73.68 | 66.21 | Upgrade
|
| Selling, General & Admin | 55.05 | 48.07 | 50.68 | 32.36 | 29.86 | 30.13 | Upgrade
|
| Other Operating Expenses | 5.05 | 4.9 | 4.74 | 14.55 | -0.01 | -1.88 | Upgrade
|
| Operating Expenses | 64.2 | 53.65 | 63.6 | 53.81 | 38.83 | 28.35 | Upgrade
|
| Operating Income | 6.57 | 9.54 | 10.57 | 47.17 | 34.86 | 37.86 | Upgrade
|
| Interest Expense | -1.86 | -1.86 | -0.42 | -2.52 | -6.9 | -10.14 | Upgrade
|
| Interest & Investment Income | 6.08 | 4.81 | 3.98 | 3.58 | 2.48 | 5.65 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.01 | 1.52 | 0.54 | 0 | -0.01 | -0.07 | Upgrade
|
| EBT Excluding Unusual Items | 11.8 | 14.01 | 14.66 | 48.23 | 30.42 | 33.3 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -2.83 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.06 | 0.04 | 0.08 | 0.01 | 0.02 | 0.01 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -1 | Upgrade
|
| Pretax Income | 11.86 | 14.04 | 14.74 | 45.41 | 30.44 | 32.31 | Upgrade
|
| Income Tax Expense | 6.88 | 8.11 | 15.44 | 16.86 | 9.59 | 7.59 | Upgrade
|
| Net Income | 4.98 | 5.93 | -0.7 | 28.55 | 20.85 | 24.71 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 1.97 | - | 1.35 | Upgrade
|
| Net Income to Common | 4.98 | 5.93 | -0.7 | 26.58 | 20.85 | 23.36 | Upgrade
|
| Net Income Growth | 67.43% | - | - | 36.92% | -15.62% | 0.42% | Upgrade
|
| Shares Outstanding (Basic) | 121 | 125 | 125 | 125 | 125 | 125 | Upgrade
|
| Shares Outstanding (Diluted) | 121 | 125 | 125 | 125 | 125 | 125 | Upgrade
|
| Shares Change (YoY) | -6.22% | - | - | - | 0.00% | - | Upgrade
|
| EPS (Basic) | 0.04 | 0.05 | -0.01 | 0.21 | 0.17 | 0.19 | Upgrade
|
| EPS (Diluted) | 0.04 | 0.05 | -0.01 | 0.21 | 0.17 | 0.19 | Upgrade
|
| EPS Growth | 78.54% | - | - | 27.47% | -10.73% | -0.61% | Upgrade
|
| Free Cash Flow | 6.34 | -17.92 | -7.4 | 40.68 | 42.38 | 4.8 | Upgrade
|
| Free Cash Flow Per Share | 0.05 | -0.14 | -0.06 | 0.33 | 0.34 | 0.04 | Upgrade
|
| Dividend Per Share | - | - | - | 0.100 | - | - | Upgrade
|
| Gross Margin | 24.05% | 22.75% | 28.41% | 36.70% | 32.69% | 30.98% | Upgrade
|
| Operating Margin | 2.23% | 3.44% | 4.05% | 17.14% | 15.46% | 17.72% | Upgrade
|
| Profit Margin | 1.69% | 2.14% | -0.27% | 9.66% | 9.25% | 10.93% | Upgrade
|
| Free Cash Flow Margin | 2.15% | -6.45% | -2.84% | 14.78% | 18.80% | 2.25% | Upgrade
|
| EBITDA | 16.76 | 19.68 | 20.8 | 72.28 | 46.81 | 48.97 | Upgrade
|
| EBITDA Margin | 5.69% | 7.08% | 7.97% | 26.27% | 20.77% | 22.92% | Upgrade
|
| D&A For EBITDA | 10.18 | 10.13 | 10.23 | 25.11 | 11.95 | 11.11 | Upgrade
|
| EBIT | 6.57 | 9.54 | 10.57 | 47.17 | 34.86 | 37.86 | Upgrade
|
| EBIT Margin | 2.23% | 3.44% | 4.05% | 17.14% | 15.46% | 17.72% | Upgrade
|
| Effective Tax Rate | 58.01% | 57.76% | 104.72% | 37.13% | 31.50% | 23.51% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.